Brighton Jones LLC Rigel Pharmaceuticals Inc Transaction History

Brighton Jones LLC

  • $2.55 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
SELL
$0.67 - $3.19 $337 - $1,607
-504 Reduced 2.58%
19,000 $21,000
Q1 2022

May 13, 2022
BUY
$2.22 - $3.45 $235 - $365
106 Added 0.55%
19,504 $58,000
Q4 2020

Feb 10, 2021
BUY
$2.35 - $3.74 $935 - $1,488
398 Added 2.09%
19,398 $68,000
Q1 2020

May 13, 2020
BUY
$1.27 - $3.0 $1,270 - $3,000
1,000 Added 5.56%
19,000 $30,000
Q3 2019

Oct 28, 2019
BUY
$1.63 - $2.62 $29,339 - $47,160
18,000 New
18,000 $34,000

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.84B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email